Average Co-Inventor Count = 3.90
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Rockefeller University (13 from 712 patents)
2. California Institute of Technology (12 from 4,548 patents)
13 patents:
1. 12428472 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof
2. 12071470 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof
3. 12054538 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
4. 11634478 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof
5. 11472868 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
6. 11155605 - Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits
7. 10889633 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof
8. 10590187 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120
9. 10421803 - Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunits
10. 9890207 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120
11. 9783594 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof
12. 9493549 - Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
13. 8673307 - HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120